Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Construction in Progress (2017 - 2020)

Champions Oncology has reported Construction in Progress over the past 4 years, most recently at $441000.0 for Q4 2020.

  • For Q4 2020, Construction in Progress changed N/A year-over-year to $441000.0; the TTM value through Oct 2020 reached $441000.0, changed N/A, while the annual FY2020 figure was $554000.0, 3362.5% up from the prior year.
  • Construction in Progress for Q4 2020 was $441000.0 at Champions Oncology, up from $114000.0 in the prior quarter.
  • Over five years, Construction in Progress peaked at $619000.0 in Q3 2019 and troughed at $15000.0 in Q2 2018.
  • A 4-year average of $196076.9 and a median of $58000.0 in 2018 define the central range for Construction in Progress.
  • Biggest five-year swings in Construction in Progress: plummeted 96.82% in 2018 and later skyrocketed 3362.5% in 2020.
  • Year by year, Construction in Progress stood at $19000.0 in 2017, then soared by 31.58% to $25000.0 in 2018, then skyrocketed by 2376.0% to $619000.0 in 2019, then decreased by 28.76% to $441000.0 in 2020.
  • Business Quant data shows Construction in Progress for CSBR at $441000.0 in Q4 2020, $114000.0 in Q3 2020, and $554000.0 in Q2 2020.